New blood test for pregnant women could predict preterm birth
In 2016, one in 10 babies in the U.S. were born before 37 weeks of pregnancy. Worldwide, preterm birth complications are the leading cause of death for children under 5
7 years ago
Your browser doesn’t support HTML5 audio
The ethics of genetic screening and ‘designer babies’
Are you ready for the era of designer babies?
Advances in gene sequencing have now made it possible for embryos to be screened for a host of genetic diseases and physical traits. Private companies are capitalizing on this technology, offering polygenic screening before embryos are implanted. They give each embryo a risk score for health conditions like heart disease, Crohn’s disease, schizophrenia and obesity, and they can also screen for characteristics like IQ, eye color and height.
Then, prospective parents can choose.
A recent Harvard University survey found a significant majority of respondents approved of using embryo screening, but what ethical questions does this new technology raise? Is this the best way to ensure healthy, happy babies? Or are we on a slippery slope to eugenics?
In this episode, we’ll weigh these ethical quandaries, and we want to hear from you: where do you draw the line on genetic screening?
Guests: